デフォルト表紙
市場調査レポート
商品コード
1606745

ドコサヘキサエン酸市場:供給源、形態、用途別-2025~2030年の世界予測

Docosahexaenoic Acid Market by Source (Algae, Fish, Krill), Form (Liquid, Powder), Application - Global Forecast 2025-2030


出版日
発行
360iResearch
ページ情報
英文 191 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.00円
ドコサヘキサエン酸市場:供給源、形態、用途別-2025~2030年の世界予測
出版日: 2024年10月31日
発行: 360iResearch
ページ情報: 英文 191 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ドコサヘキサエン酸市場は、2023年に5億6,953万米ドルと評価され、2024年には6億195万米ドルに達すると予測され、CAGR 5.81%で成長し、2030年には8億4,586万米ドルに達すると予測されています。

ドコサヘキサエン酸(DHA)は、主に魚油に含まれるオメガ3脂肪酸で、脳の健康、視力、炎症の軽減に重要です。DHAの市場規模は、栄養補助食品、乳児用調製粉乳、強化食品・飲食品、医薬品に必要なものであり、その健康上の利点は数多くあります。その用途は認知機能の発達、心臓血管の健康、抗炎症特性から潜在的な精神衛生上の利点まで多岐にわたるため、小児科から高齢者科まで幅広い最終用途にアピールすることができます。成長に影響を与える主要要因としては、オメガ3脂肪酸の健康上の利点に対する消費者の意識の高まり、生活習慣病の罹患率の上昇、強化食品に対する需要の急増などが挙げられます。さらに、生産方法の技術的進歩や製品ポートフォリオの拡大が市場拡大の原動力となっています。最新のビジネス機会は、植物由来のDHA供給源を必要とする菜食主義者やベジタリアンの人口増加、セルフケアや予防的健康対策の傾向の高まりにあり、サプリメントや機能性食品の技術革新の基盤となっています。しかし、高い生産コスト、厳しい規制環境、海洋由来の持続可能性や資源枯渇に対する懸念といった課題が大きく立ちはだかっています。市場はまた、経済的制約や認識不足のために、新興国地域の消費者が入手しやすいかどうかという限界にも直面しています。技術革新が必要とされるセグメントには、藻類をベースとした持続可能で効率的なDHA生産の開発、個別化栄養ソリューションの開発、バイオアベイラビリティを高めるための新規送達システムへのDHAの統合などがあります。市場力学は、健康動向と技術進歩に牽引され、戦略的パートナーシップ、植物由来の製品への多様化、消費者を教育し引き込むためのデジタルマーケティングの活用を通じてビジネスが成功する、競争的だが有望な情勢を示唆しています。この進化する市場で長期的に成功するためには、持続可能性と透明性を重視することが重要です。

主要市場の統計
基準年[2023年] 5億6,953万米ドル
推定年[2024年] 6億195万米ドル
予測年[2030年] 8億4,586万米ドル
CAGR(%) 5.81%

市場力学:急速に進化するドコサヘキサエン酸市場の主要市場洞察を公開

ドコサヘキサエン酸市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネス機会の獲得に備えることができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

  • 市場促進要因
    • 人口の慢性疾患有病率の上昇
    • 栄養食品メーカーや乳児用食品メーカーからのDHA需要の増加
    • 健康意識の高まりと医療支出の増加
  • 市場抑制要因
    • DHA製造に必要な原料価格の変動
  • 市場機会
    • 動物性不使用のオメガ3成分の開発
    • 神経発達、神経細胞機能、学習、記憶におけるDHAの用途
  • 市場課題
    • DHAの副作用に関連する可能性

ポーターのファイブフォース:ドコサヘキサエン酸市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析:ドコサヘキサエン酸市場における外部からの影響の把握

外部マクロ環境要因は、ドコサヘキサエン酸市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析:ドコサヘキサエン酸市場における競合情勢の把握

ドコサヘキサエン酸市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス:ドコサヘキサエン酸市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、ドコサヘキサエン酸市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨:ドコサヘキサエン酸市場における成功への道筋を描く

ドコサヘキサエン酸市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネス機会を活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目セグメントを網羅した市場の包括的な分析を提供しています。

1.市場の浸透度:現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力を評価します。

2.市場の開拓度:新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化:最近の製品発売、未開拓の地域、産業の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報:競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション:将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は?

2.最高の投資機会を提供する製品、地域はどこか?

3.市場を形成する主要技術動向と規制の影響とは?

4.主要ベンダーの市場シェアと競合ポジションは?

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 人口における慢性疾患の罹患率の上昇
      • 栄養食品と乳児用食品メーカーからのDHAの需要増加
      • 健康意識の高まりと医療費の増加
    • 抑制要因
      • DHA製造に必要な原料価格の変動
    • 機会
      • 動物由来でないオメガ3原料の開発
      • 神経発達、神経機能、学習、記憶におけるDHAの用途
    • 課題
      • DHAの副作用に関連する可能性
  • 市場セグメンテーション分析
  • ポーターのファイブフォース分析
  • PESTEL分析
    • 政治
    • 経済
    • 社会
    • 技術
    • 法律
    • 環境

第6章 ドコサヘキサエン酸市場:供給源別

  • イントロダクション
  • 藻類
  • オキアミ

第7章 ドコサヘキサエン酸市場:形態別

  • イントロダクション
  • 液体
  • 粉末

第8章 ドコサヘキサエン酸市場:用途別

  • イントロダクション
  • 栄養補助食品
  • 機能性飲食品
  • 乳児用調合乳
  • 医薬品

第9章 南北アメリカのドコサヘキサエン酸市場

  • イントロダクション
  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋のドコサヘキサエン酸市場

  • イントロダクション
  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカのドコサヘキサエン酸市場

  • イントロダクション
  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • 市場シェア分析、2023年
  • FPNVポジショニングマトリックス、2023年
  • 競合シナリオ分析
  • 戦略分析と提言

企業一覧

  • Archer Daniels Midland Company
  • BASF SE
  • Biofermen Private Limited
  • Biomol GmbH by Nordic BioSite Group
  • Biosynth Ltd.
  • BLD Pharmatech Ltd.
  • Broad Group
  • CABIO BIoTech(Wuhan)Co., Ltd.
  • Cayman Chemical Company
  • Cellana, Inc.
  • Corbion NV
  • Croda International Plc
  • Evonik Industries AG
  • Golden Omega S.A.
  • KD Pharma Group
  • Kingdomway Nutrition, Inc.
  • Koninklijke DSM N.V.
  • Merck KGaA
  • Nordic Naturals
  • Novotech Nutraceuticals, Inc.
  • Omega Protein Corporation
  • Pharma House
  • Thermo Fisher Scientific Inc.
  • Tokyo Chemical Industry Co., Ltd.
  • TRC Inc.
図表

LIST OF FIGURES

  • FIGURE 1. DOCOSAHEXAENOIC ACID MARKET RESEARCH PROCESS
  • FIGURE 2. DOCOSAHEXAENOIC ACID MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DOCOSAHEXAENOIC ACID MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DOCOSAHEXAENOIC ACID MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DOCOSAHEXAENOIC ACID MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DOCOSAHEXAENOIC ACID MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DOCOSAHEXAENOIC ACID MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DOCOSAHEXAENOIC ACID MARKET SIZE, BY FORM, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DOCOSAHEXAENOIC ACID MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DOCOSAHEXAENOIC ACID MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL DOCOSAHEXAENOIC ACID MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS DOCOSAHEXAENOIC ACID MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS DOCOSAHEXAENOIC ACID MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES DOCOSAHEXAENOIC ACID MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES DOCOSAHEXAENOIC ACID MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC DOCOSAHEXAENOIC ACID MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC DOCOSAHEXAENOIC ACID MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DOCOSAHEXAENOIC ACID MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DOCOSAHEXAENOIC ACID MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. DOCOSAHEXAENOIC ACID MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. DOCOSAHEXAENOIC ACID MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DOCOSAHEXAENOIC ACID MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DOCOSAHEXAENOIC ACID MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DOCOSAHEXAENOIC ACID MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DOCOSAHEXAENOIC ACID MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DOCOSAHEXAENOIC ACID MARKET DYNAMICS
  • TABLE 7. GLOBAL DOCOSAHEXAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DOCOSAHEXAENOIC ACID MARKET SIZE, BY ALGAE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DOCOSAHEXAENOIC ACID MARKET SIZE, BY FISH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DOCOSAHEXAENOIC ACID MARKET SIZE, BY KRILL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DOCOSAHEXAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DOCOSAHEXAENOIC ACID MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DOCOSAHEXAENOIC ACID MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DOCOSAHEXAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DOCOSAHEXAENOIC ACID MARKET SIZE, BY DIETARY SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DOCOSAHEXAENOIC ACID MARKET SIZE, BY FUNCTIONAL FOOD & BEVERAGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DOCOSAHEXAENOIC ACID MARKET SIZE, BY INFANT FORMULAE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DOCOSAHEXAENOIC ACID MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS DOCOSAHEXAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS DOCOSAHEXAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS DOCOSAHEXAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS DOCOSAHEXAENOIC ACID MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA DOCOSAHEXAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA DOCOSAHEXAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA DOCOSAHEXAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL DOCOSAHEXAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL DOCOSAHEXAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL DOCOSAHEXAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA DOCOSAHEXAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA DOCOSAHEXAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA DOCOSAHEXAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO DOCOSAHEXAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO DOCOSAHEXAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO DOCOSAHEXAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES DOCOSAHEXAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES DOCOSAHEXAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES DOCOSAHEXAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES DOCOSAHEXAENOIC ACID MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC DOCOSAHEXAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC DOCOSAHEXAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC DOCOSAHEXAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC DOCOSAHEXAENOIC ACID MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA DOCOSAHEXAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA DOCOSAHEXAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA DOCOSAHEXAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA DOCOSAHEXAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA DOCOSAHEXAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA DOCOSAHEXAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA DOCOSAHEXAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA DOCOSAHEXAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA DOCOSAHEXAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA DOCOSAHEXAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA DOCOSAHEXAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA DOCOSAHEXAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN DOCOSAHEXAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN DOCOSAHEXAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN DOCOSAHEXAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA DOCOSAHEXAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA DOCOSAHEXAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA DOCOSAHEXAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES DOCOSAHEXAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES DOCOSAHEXAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES DOCOSAHEXAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE DOCOSAHEXAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE DOCOSAHEXAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE DOCOSAHEXAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA DOCOSAHEXAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA DOCOSAHEXAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA DOCOSAHEXAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN DOCOSAHEXAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN DOCOSAHEXAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN DOCOSAHEXAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND DOCOSAHEXAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND DOCOSAHEXAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND DOCOSAHEXAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM DOCOSAHEXAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM DOCOSAHEXAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM DOCOSAHEXAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA DOCOSAHEXAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA DOCOSAHEXAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA DOCOSAHEXAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA DOCOSAHEXAENOIC ACID MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK DOCOSAHEXAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK DOCOSAHEXAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK DOCOSAHEXAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT DOCOSAHEXAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT DOCOSAHEXAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT DOCOSAHEXAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND DOCOSAHEXAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND DOCOSAHEXAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND DOCOSAHEXAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE DOCOSAHEXAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE DOCOSAHEXAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE DOCOSAHEXAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY DOCOSAHEXAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY DOCOSAHEXAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY DOCOSAHEXAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL DOCOSAHEXAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL DOCOSAHEXAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL DOCOSAHEXAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY DOCOSAHEXAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY DOCOSAHEXAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY DOCOSAHEXAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS DOCOSAHEXAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS DOCOSAHEXAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS DOCOSAHEXAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA DOCOSAHEXAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA DOCOSAHEXAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA DOCOSAHEXAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY DOCOSAHEXAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY DOCOSAHEXAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY DOCOSAHEXAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND DOCOSAHEXAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND DOCOSAHEXAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND DOCOSAHEXAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR DOCOSAHEXAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR DOCOSAHEXAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR DOCOSAHEXAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA DOCOSAHEXAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA DOCOSAHEXAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA DOCOSAHEXAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA DOCOSAHEXAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA DOCOSAHEXAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA DOCOSAHEXAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA DOCOSAHEXAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA DOCOSAHEXAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA DOCOSAHEXAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN DOCOSAHEXAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN DOCOSAHEXAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN DOCOSAHEXAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN DOCOSAHEXAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN DOCOSAHEXAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN DOCOSAHEXAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND DOCOSAHEXAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND DOCOSAHEXAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND DOCOSAHEXAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY DOCOSAHEXAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY DOCOSAHEXAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY DOCOSAHEXAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES DOCOSAHEXAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES DOCOSAHEXAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES DOCOSAHEXAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM DOCOSAHEXAENOIC ACID MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM DOCOSAHEXAENOIC ACID MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM DOCOSAHEXAENOIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. DOCOSAHEXAENOIC ACID MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. DOCOSAHEXAENOIC ACID MARKET, FPNV POSITIONING MATRIX, 2023
目次
Product Code: MRR-C002B1C996E9

The Docosahexaenoic Acid Market was valued at USD 569.53 million in 2023, expected to reach USD 601.95 million in 2024, and is projected to grow at a CAGR of 5.81%, to USD 845.86 million by 2030.

Docosahexaenoic Acid (DHA) is an omega-3 fatty acid primarily found in fish oils, critical for brain health, vision, and reducing inflammation. The market scope for DHA encompasses its necessity in nutritional supplements, infant formulas, fortified foods and beverages, and pharmaceuticals due to its numerous health benefits. Applications span from cognitive development, cardiovascular health, and anti-inflammatory properties to potential mental health benefits, thus appealing to a broad end-use spectrum ranging from pediatrics to geriatrics. Key influencing growth factors include increasing consumer awareness of the health advantages of omega-3 fatty acids, rising incidences of lifestyle-related diseases, and a surge in demand for fortified foods. Furthermore, technological advancements in production methods and expanding product portfolios are driving market expansion. The latest opportunities lie in the growing vegan and vegetarian demographics, needing plant-based DHA sources, and the increasing trend of self-care and preventive health measures, offering a platform for innovation in supplements and functional foods. However, challenges such as high production costs, stringent regulatory environments, and concerns over sustainability and resource depletion of marine sources loom large. The market also faces limitations in consumer accessibility in developing regions due to economic constraints and lack of awareness. Areas ripe for innovation include developing sustainable and efficient algae-based DHA production, creating personalized nutrition solutions, and integrating DHA in novel delivery systems for enhanced bioavailability. Market dynamics suggest a competitive but promising landscape driven by health trends and technological progress, where businesses can thrive through strategic partnerships, diversification into plant-based offerings, and leveraging digital marketing to educate and engage consumers. Emphasis on sustainability and transparency will be crucial for long-term success in this evolving market.

KEY MARKET STATISTICS
Base Year [2023] USD 569.53 million
Estimated Year [2024] USD 601.95 million
Forecast Year [2030] USD 845.86 million
CAGR (%) 5.81%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Docosahexaenoic Acid Market

The Docosahexaenoic Acid Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of chronic diseases among population
    • Increasing demand for DHA from nutritional and infant food manufacturers
    • Growing health awareness and rising healthcare spending
  • Market Restraints
    • Fluctuating prices of raw materials required for DHA manufacturing
  • Market Opportunities
    • Development of animal free omega-3 ingredients
    • Applications of DHA in neurodevelopment, neuronal functions, learning and memory
  • Market Challenges
    • Possibilities associated with side effects of DHA

Porter's Five Forces: A Strategic Tool for Navigating the Docosahexaenoic Acid Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Docosahexaenoic Acid Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Docosahexaenoic Acid Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Docosahexaenoic Acid Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Docosahexaenoic Acid Market

A detailed market share analysis in the Docosahexaenoic Acid Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Docosahexaenoic Acid Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Docosahexaenoic Acid Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Docosahexaenoic Acid Market

A strategic analysis of the Docosahexaenoic Acid Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Docosahexaenoic Acid Market, highlighting leading vendors and their innovative profiles. These include Archer Daniels Midland Company, BASF SE, Biofermen Private Limited, Biomol GmbH by Nordic BioSite Group, Biosynth Ltd., BLD Pharmatech Ltd., Broad Group, CABIO Biotech (Wuhan) Co., Ltd., Cayman Chemical Company, Cellana, Inc., Corbion NV, Croda International Plc, Evonik Industries AG, Golden Omega S.A., KD Pharma Group, Kingdomway Nutrition, Inc., Koninklijke DSM N.V., Merck KGaA, Nordic Naturals, Novotech Nutraceuticals, Inc., Omega Protein Corporation, Pharma House, Thermo Fisher Scientific Inc., Tokyo Chemical Industry Co., Ltd., and TRC Inc..

Market Segmentation & Coverage

This research report categorizes the Docosahexaenoic Acid Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Source, market is studied across Algae, Fish, and Krill.
  • Based on Form, market is studied across Liquid and Powder.
  • Based on Application, market is studied across Dietary Supplements, Functional Food & Beverages, Infant Formulae, and Pharmaceuticals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of chronic diseases among population
      • 5.1.1.2. Increasing demand for DHA from nutritional and infant food manufacturers
      • 5.1.1.3. Growing health awareness and rising healthcare spending
    • 5.1.2. Restraints
      • 5.1.2.1. Fluctuating prices of raw materials required for DHA manufacturing
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of animal free omega-3 ingredients
      • 5.1.3.2. Applications of DHA in neurodevelopment, neuronal functions, learning and memory
    • 5.1.4. Challenges
      • 5.1.4.1. Possibilities associated with side effects of DHA
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Docosahexaenoic Acid Market, by Source

  • 6.1. Introduction
  • 6.2. Algae
  • 6.3. Fish
  • 6.4. Krill

7. Docosahexaenoic Acid Market, by Form

  • 7.1. Introduction
  • 7.2. Liquid
  • 7.3. Powder

8. Docosahexaenoic Acid Market, by Application

  • 8.1. Introduction
  • 8.2. Dietary Supplements
  • 8.3. Functional Food & Beverages
  • 8.4. Infant Formulae
  • 8.5. Pharmaceuticals

9. Americas Docosahexaenoic Acid Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Docosahexaenoic Acid Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Docosahexaenoic Acid Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Archer Daniels Midland Company
  • 2. BASF SE
  • 3. Biofermen Private Limited
  • 4. Biomol GmbH by Nordic BioSite Group
  • 5. Biosynth Ltd.
  • 6. BLD Pharmatech Ltd.
  • 7. Broad Group
  • 8. CABIO Biotech (Wuhan) Co., Ltd.
  • 9. Cayman Chemical Company
  • 10. Cellana, Inc.
  • 11. Corbion NV
  • 12. Croda International Plc
  • 13. Evonik Industries AG
  • 14. Golden Omega S.A.
  • 15. KD Pharma Group
  • 16. Kingdomway Nutrition, Inc.
  • 17. Koninklijke DSM N.V.
  • 18. Merck KGaA
  • 19. Nordic Naturals
  • 20. Novotech Nutraceuticals, Inc.
  • 21. Omega Protein Corporation
  • 22. Pharma House
  • 23. Thermo Fisher Scientific Inc.
  • 24. Tokyo Chemical Industry Co., Ltd.
  • 25. TRC Inc.